Profil
Cristina Ghenoiu is currently the Senior VP-Research & Development Operations at Epirium Bio, Inc. and the Senior Principal at Mubadala Capital LLC.
Previously, she worked as an Associate at Cowen & Co. LLC from 2013 to 2016 and as a Research Scientist at The Rockefeller University in 2012.
She also served as a Principal at RA Capital Management LP (Private Equity) from 2021 to 2023.
Dr. Ghenoiu holds a doctorate degree from Cornell University, which she obtained in 2012, and an undergraduate degree from Mount Holyoke College, which she received in 2004.
Postes actifs de Cristina Ghenoiu
| Sociétés | Poste | Début |
|---|---|---|
Epirium Bio, Inc.
Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Directeur Technique/Scientifique/R&D | 01/01/2020 |
Mubadala Capital LLC
Mubadala Capital LLC Investment ManagersFinance Mubadala Capital invests in companies globally, primarily in North America and Europe. The firm targets companies operating in the fields of healthcare, financials, technology, real estate & infrastructure, energy and consumer service sectors. It provides financing for early and growth stage capital requirements with an investment size ranging from USD 50 - 250 million. The firm acquires minority and controlling interest and acts as lead investor. It also makes co-investments. | Private Equity Investor | 01/09/2023 |
Anciens postes connus de Cristina Ghenoiu
| Sociétés | Poste | Fin |
|---|---|---|
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Corporate Officer/Principal | 01/09/2023 |
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/08/2016 |
The Rockefeller University
The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 31/12/2012 |
Formation de Cristina Ghenoiu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Epirium Bio, Inc.
Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mount Holyoke College
Mount Holyoke College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Rockefeller University
The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mubadala Capital LLC
Mubadala Capital LLC Investment ManagersFinance Mubadala Capital invests in companies globally, primarily in North America and Europe. The firm targets companies operating in the fields of healthcare, financials, technology, real estate & infrastructure, energy and consumer service sectors. It provides financing for early and growth stage capital requirements with an investment size ranging from USD 50 - 250 million. The firm acquires minority and controlling interest and acts as lead investor. It also makes co-investments. | Finance |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Finance |
















